Humacyte, Inc. (HUMA) NASDAQ
0.64
+0.0505(+8.53%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 151.91M |
| Enterprise Value | 166.26M |
| P/E Ratio | -2.49 |
| PEG Ratio | -0.57 |
| Price/Sales Ratio | 49.42 |
| Price/Book Ratio | 32.68 |
| Enterprise/Revenue | 56.46 |
| Enterprise/EBITDA | -1.15 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
Profitability
| Profit Margin | -20.04 |
| Operating Margin | -53.06 |
Management Effectiveness
| Return On Assets | -0.35 |
| Return On Equity | -4.25 |
Income Statement
| Revenue | 2.04M |
| Revenue/Share | 0.01 |
| Gross Profit | -15.01M |
| EBITDA | -100.09M |
| Net Income | -40.83M |
| Diluted EPS | -0.26 |
Balance Sheet
| Total Cash | 50.5M |
| Total Cash/Share | 0.32 |
| Total Debt | 64.85M |
| Total Debt/Equity | 20.86 |
| Current Ratio | 3.69 |
| Book Value Per Share | 0.02 |
Price History
| 52-Week Change | -49.02 |
| 52-Week High | 2.93 |
| 52-Week Low | 0.55 |
| Moving Average 50 Days | 1.01 |
| Moving Average 200 Days | 1.5 |
Statistics
| Average Volume | 6.96M |
| Shares Outstanding | 156.77M |
| % Held by Institutions | 34.93 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
